Age-related Macular Degeneration Market Size, Embracing Growth Opportunities in 2025-2031
The Age-related Macular Degeneration (AMD) Market refers to the global market for treatments, therapies, diagnostics, and related services aimed at managing and treating age-related macular degeneration, a leading cause of vision loss in older adults. AMD affects the macula, the central part of the retina responsible for sharp vision. The market includes various products such as pharmaceuticals (e.g., anti-VEGF injections), medical devices (e.g., implants, diagnostic tools), and emerging therapies (e.g., gene therapy, stem cell therapy) designed to slow disease progression, improve vision, or prevent blindness in patients with AMD.
Some of the key players profiled in the study are Novartis International AG (Switzerland), Regeneron Pharmaceuticals, Inc. (United States), Roche Holding AG (Switzerland), Bayer AG (Germany), Alcon Inc. (Switzerland), Apellis Pharmaceuticals, Inc. (United States), Ocular Therapeutix, Inc. (United States), Eylea (Bayer/Regeneron) (United States/Germany), Lux Biosciences, Inc. (United States), Kite Pharma (Gilead Sciences, Inc.) (United States).
According to HTF Market Intelligence, the Global Age-related Macular Degeneration market to witness a CAGR of 6.2% during forecast period of 2025-2031. Global Age-related Macular Degeneration Market Breakdown by Application (Hospital & Clinics, Diagnostic Centers, Academic Research Institutes, Others) by Type (Dry AMD, Wet AMD) by Drug (Aflibercept, Ranibizumab, Brolucizumab, Others) by Gender (Male, Female) and by Geography (North America, South America, Europe, Asia Pacific, MEA). The report includes historic market data from 2020 to 2024E. Currently, market value is pegged at USD 11 Billion.
Market Trends:
- The move towards personalized medicine
- The integration of artificial intelligence (AI) and machine learning in diagnostics
Market Drivers:
- The aging global population, as the prevalence of AMD increases
- The rising awareness of AMD and early diagnosis programs are encouraging more patients to seek treatment at earlier stages
Market Opportunities:
- The potential for combination therapies opens avenues for companies to develop more comprehensive treatment
- Increasing healthcare access and rising awareness
Market Challenges:
- The high treatment costs being a significant barrier
- The complexity of developing new therapies, particularly gene and cell-based treatments
Book Latest Edition of Global Age-related Macular Degeneration Market Study @ https://www.htfmarketintelligence.com/buy-now?format=1&report=11822
About Us:
HTF Market Intelligence is a leading market research company providing end-to-end syndicated and custom market reports, consulting services, and insightful information across the globe. HTF MI integrates History, Trends, and Forecasts to identify the highest value opportunities, cope with the most critical business challenges and transform the businesses. Analysts at HTF MI focuses on comprehending the unique needs of each client to deliver insights that are most suited to his particular requirements.
Contact Us:
Nidhi Bhavsar (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Phone: +15075562445
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.
| Online: | |
| Visits: | 1,694,851,083 |
| Stories: | 8,412,618 |
Whistler Blowers, Insiders
